Chiara Verpelli

Vedano Al Lambro, 20854, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

Journal: Translational psychiatry

Published: June 22, 2025

ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization.

ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: September 02, 2024

Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndrome.

Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndrome.

Journal: Molecular psychiatry

Published: June 26, 2024

Regulation of Dendrite and Dendritic Spine Formation by TCF20.

Regulation of Dendrite and Dendritic Spine Formation by TCF20.

Journal: Journal of neurochemistry

Published: June 07, 2024

Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling.

Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling.

Journal: Molecular autism

Published: December 11, 2022

Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.

Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.

Journal: European journal of medical genetics

Published: December 10, 2022

Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model.

Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model.

Journal: Molecular autism

Published: October 27, 2022

Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.

Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.

Journal: Neuroscience applied

Published: September 12, 2022

Shank2/3 double knockout-based screening of cortical subregions links the retrosplenial area to the loss of social memory in autism spectrum disorders.

Shank2/3 double knockout-based screening of cortical subregions links the retrosplenial area to the loss of social memory in autism spectrum disorders.

Journal: Molecular psychiatry

Published: October 20, 2021

Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer's disease and epilepsy and predisposes to seizures.

Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer's disease and epilepsy and predisposes to seizures.

Journal: Cell calcium

Published: August 15, 2021

Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).

Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).

Journal: Molecular autism

Published: July 29, 2021

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 25, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026